Epidemiology of antituberculosis drug resistance in Saudi Arabia: Findings of the first national survey

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2161-2166

  Al Hajoj, Sahal ^a   Varghese, Bright ^a   Shoukri, Mohammed M ^a   Al Omari, Ruba ^a   Al Herbwai, Mais ^a   AlRabiah, Fahad ^a   Alrajhi, Abdulrahman A ^a   Abuljadayel, Naila ^b   Al Thawadi, Sahar ^a   Zumla, Alimuddin ^c   Zignol, Matteo ^d   Raviglione, Mario C ^d   Memish, Ziad ^b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MALE; MIGRANT WORKER; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SAUDI ARABIA;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; ETHAMBUTOL; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; ISONIAZID; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; RISK FACTORS; SAUDI ARABIA; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84876227698     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02403-12     Document Type: Article

References (25)

1. Raviglione MC, Marais B, Floyd K, Lonnroth K, Getahun H, Migliori GB, Harries AD, Nunn P, Lienhardt C, Graham S, Chakaya J, Weyer K, Cole S, Kaufmann SH, Zumla A. 2012. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379:1902-1913.
2. World Health Organization. 2011. Global tuberculosis control report 2011. World Health Organization, Geneva, Switzerland.
3. World Health Organization. 2010. Multidrug and extensively drugresistant TB (M/XDR-TB): 2010 global report on surveillance and response. World Health Organization, Geneva, Switzerland.
4. Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M. 2012. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull. World Health Organ. 90:111-119D.
5. Abu-Amero KK. 2002. Status of antituberculosis drug resistance in Saudi Arabia 1979-98. East Mediterr. Health J. 8:664-670.
6. Al-Hajoj SA, Zozio T, Al-Rabiah F, Mohammad V, Al-Nasser M, Sola C, Rastogi N. 2007. First insight into the population structure of Mycobacterium tuberculosis in Saudi Arabia. J. Clin. Microbiol. 45:2467-2473.
7. Al-Rubaish AM, Madania AA, Al-Muhanna FA. 2001. Drug resistance pulmonary tuberculosis in the eastern province of Saudi Arabia. Saudi Med. J. 22:776-779.
8. Alrajhi AA, Al-Barrak AM. 2002. Mycobacterium tuberculosis susceptibility in Saudi Arabia. Saudi Med. J. 23:1227-1231.
9. Ellis ME, al-Hajjar S, Bokhari H, Hussein Qadri SM. 1996. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand. J. Infect. Dis. 28:591-595.
10. Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z. 2001. Increasing resistance of Mycobacterium tuberculosis to anti-TB drugs in Saudi Arabia. Int. J. Antimicrob. Agents 17:415-418.
11. Kordy FN, Al-Thawadi S, Alrajhi AA. 2004. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int. J. Tuberc. Lung Dis. 8:1007-1011.
12. Central department of statistics and information. 2011. Statistical year book - 2010. Ministry of Economy and Planning, Kingdom of Saudi Arabia, Riyadh, Saudi Arabia.
13. Alzeer A, Mashlah A, Fakim N, Al-Sugair N, Al-Hedaithy M, Al-Majed S, Jamjoom G. 1998. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J. Infect. 36:303-306.
14. Al-Jasser FS, Kabbash IA, Almazroa MA, Memish ZA. 2012. Patterns of diseases and preventive measures among domestic hajjis from Central, Saudi Arabia. Saudi Med. J. 33:879-886.
15. Gleason JA, McNabb SJ, Abduljadayel N, Abouzeid MS, Memish ZA 2012. Tuberculosis trends in the Kingdom of Saudi Arabia, 2005 to 2009. Ann. Epidemiol. 22:264-269.
16. Wilder-Smith A, Foo W, Earnest A, Paton NI. 2005. High risk of Mycobacterium tuberculosis infection during the Hajj pilgrimage. Trop. Med. Int. Health 10:336-339.
17. World Health Organization. 2009. Guidelines for surveillance of drug resistance in tuberculosis, 4th ed. World Health Organization, Geneva, Switzerland.
18. Zignol M, van Gemert W, Falzon D, Jaramillo E, Blanc L, Raviglione MC. 2011. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin. Infect. Dis. 52:901-906.
19. Ministry of Health of Russian Federation. 2011. Tuberculosis in the Russian federation - 2010. Ministry of Health of Russian Federation, Moscow, Russia.
20. Faustini A, Hall AJ, Perucci CA. 2006. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 61:158-163.
21. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, Cohn DL, Lambregts-van Weezenbeek CS, Kim SJ, Chaulet P, Nunn P. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti- Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 338: 1641-1649.
22. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Boulabhal F, Paramasivan CN, Kam KM, Mitarai S, Nunn P, Raviglione M. 2009. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373:1861-1873.
23. Al-Otaibi F, El Hazmi MM. 2010. Extra-pulmonary tuberculosis in Saudi Arabia. Indian J. Pathol. Microbiol. 53:227-231.
24. Bukhary ZA, Alrajhi AA. 2004. Extrapulmonary tuberculosis, clinical presentation and outcome. Saudi Med. J. 25:881-885.
25. Omair MA, Al-Ghamdi AA, Alrajhi AA. 2010. Incidence of tuberculosis in people living with the human immunodeficiency virus in Saudi Arabia. Int. J. Tuberc. Lung Dis. 14:600-603.